Application‑based Manganese Iodide segmentation reveals four dominant end‑use categories. In the pharmaceutical sector, MnI₂ functions as a precursor for iodinated compounds, representing the largest revenue slice at about 40 % owing to steady demand for radiopharmaceuticals and therapeutic agents. The catalyst segment, encompassing organic synthesis and hydrogenation processes, contributes roughly 30 % of sales, reflecting its role in high‑value specialty chemicals. Electronics, primarily for thin‑film deposition and magnetic materials, accounts for 20 % of the market, driven by growth in semiconductor and data‑storage technologies. Finally, research and development activities, including academic and industrial labs, capture the remaining 10 %, where bulk purchases are limited but essential for innovation pipelines. These application shares are reflected in the accompanying pie‑chart, illustrating the proportional impact of each use‑case on the overall market.